Skip to content

Effect of 3D Typing on Surgical Treatment of Hepatolithiasis

Efficacy of 3D Typing and Routine Typing on Surgical Treatment of Hepatolithiasis

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03098251
Enrollment
400
Registered
2017-03-31
Start date
2017-04-11
Completion date
2018-12-31
Last updated
2017-04-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hepatolithiasis, Surgery

Brief summary

According to a large amount of case affected with hepatolithiasis, we developed a typing system of Hepatolithiasis based on 3D digital conformation. And we hypothesized that it could predict a more precise construction of this disease, hence, typing by 3D conformation will improve the outcome of surgical treatment.The investigators will use a multicenter ambispective cohort study to test this hypothesis.

Detailed description

According to a large amount of case affected with hepatolithiasis, we developed a typing system of Hepatolithiasis based on 3D digital conformation. And we hypothesized that it could predict a more precise construction of this disease, hence, typing by 3D conformation will improve the outcome of surgical treatment.The investigators will use a multicenter ambispective cohort study to test this hypothesis. In this cohort study, two group will be enrolled to compare the outcomes.

Interventions

PROCEDUREroutine typing

typing the patient with routine typing system and give specific treatment

PROCEDURE3D typing

typing the patient with 3D typing system and give specific treatment

Sponsors

Second Affiliated Hospital, School of Medicine, Zhejiang University
CollaboratorOTHER
Chinese PLA General Hospital
CollaboratorOTHER
Southwest Hospital, China
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* Aged from 18 to 65 years old * Without gender restriction * With a favorable liver function of Child-Pugh A to B * No contraindications to surgery and anesthesia * Diagnosed with Hepatolithiasis and Signed informed consent.

Exclusion criteria

* Diffused type of Hepatolithiasis * Impairment in liver function * Severe disorders in vital organ * Accompanied with tumors.

Design outcomes

Primary

MeasureTime frameDescription
residual ratio of biliary stone3 monthsresidual ratio of biliary stone diagnosed within 3 months

Secondary

MeasureTime frameDescription
postoperative complications6 monthspostoperative complications diagnosed within 6 months
residual lesions6 monthsresidual lesions diagnosed within 6 months
Health economics index3 monthsHealth economics index within 3 months
mortality3 monthsmortality occured within 3 months

Countries

China

Contacts

Primary ContactXiaobin Feng, MD
fengxiaobin200708@aliyun.com+86-2368765297

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026